This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2007:590:195-208.

doi: 10.1007/978-0-387-34814-8_14.

CD4+ T cells cooperate with macrophages for specific elimination of MHC class II-negative cancer cells

Alexandre Corthay¹

Affiliations

PMID: 17191387
DOI: 10.1007/978-0-387-34814-8_14

Review

CD4+ T cells cooperate with macrophages for specific elimination of MHC class II-negative cancer cells

Alexandre Corthay. Adv Exp Med Biol. 2007.

. 2007:590:195-208.

doi: 10.1007/978-0-387-34814-8_14.

Author

Alexandre Corthay¹

Affiliation

¹ Institute of Immunology, University of Oslo and Rikshospitalet-Radiumhospitalet Medical Center, 0027 Oslo, Norway. Alexandre.Corthay@medisin.uio.no

PMID: 17191387
DOI: 10.1007/978-0-387-34814-8_14

No abstract available

PubMed Disclaimer

Similar articles

Primary antitumor immune response mediated by CD4+ T cells.
Corthay A, Skovseth DK, Lundin KU, Røsjø E, Omholt H, Hofgaard PO, Haraldsen G, Bogen B. Corthay A, et al. Immunity. 2005 Mar;22(3):371-83. doi: 10.1016/j.immuni.2005.02.003. Immunity. 2005. PMID: 15780993
Secretion of tumor-specific antigen by myeloma cells is required for cancer immunosurveillance by CD4+ T cells.
Corthay A, Lundin KU, Lorvik KB, Hofgaard PO, Bogen B. Corthay A, et al. Cancer Res. 2009 Jul 15;69(14):5901-7. doi: 10.1158/0008-5472.CAN-08-4816. Epub 2009 Jun 30. Cancer Res. 2009. PMID: 19567679
Killing of rat adenocarcinoma 13762 in situ by adoptive transfer of CD4+ anti-tumor T cells requires tumor expression of cell surface MHC class II molecules.
Frey AB, Cestari S. Frey AB, et al. Cell Immunol. 1997 May 25;178(1):79-90. doi: 10.1006/cimm.1997.1122. Cell Immunol. 1997. PMID: 9184701
MHC class II restricted neoantigen: A promising target in tumor immunotherapy.
Sun Z, Chen F, Meng F, Wei J, Liu B. Sun Z, et al. Cancer Lett. 2017 Apr 28;392:17-25. doi: 10.1016/j.canlet.2016.12.039. Epub 2017 Jan 16. Cancer Lett. 2017. PMID: 28104443 Review.
T cells work together to fight cancer.
Cerundolo V. Cerundolo V. Curr Biol. 1999 Sep 23;9(18):R695-7. doi: 10.1016/s0960-9822(99)80442-4. Curr Biol. 1999. PMID: 10508600 Review.

See all similar articles

Cited by

Immune Cell Composition in Human Non-small Cell Lung Cancer.
Stankovic B, Bjørhovde HAK, Skarshaug R, Aamodt H, Frafjord A, Müller E, Hammarström C, Beraki K, Bækkevold ES, Woldbæk PR, Helland Å, Brustugun OT, Øynebråten I, Corthay A. Stankovic B, et al. Front Immunol. 2019 Feb 1;9:3101. doi: 10.3389/fimmu.2018.03101. eCollection 2018. Front Immunol. 2019. PMID: 30774636 Free PMC article.
Harnessing dendritic cells for tumor antigen presentation.
Nierkens S, Janssen EM. Nierkens S, et al. Cancers (Basel). 2011 Apr 26;3(2):2195-213. doi: 10.3390/cancers3022195. Cancers (Basel). 2011. PMID: 24212804 Free PMC article.
A dystrophic muscle broadens the contribution and activation of immune cells reacting to rAAV gene transfer.
Ferrand M, Galy A, Boisgerault F. Ferrand M, et al. Gene Ther. 2014 Sep;21(9):828-39. doi: 10.1038/gt.2014.61. Epub 2014 Jul 17. Gene Ther. 2014. PMID: 25030611 Free PMC article.
Tumor-specific CD4+ T cells develop cytotoxic activity and eliminate virus-induced tumor cells in the absence of regulatory T cells.
Akhmetzyanova I, Zelinskyy G, Schimmer S, Brandau S, Altenhoff P, Sparwasser T, Dittmer U. Akhmetzyanova I, et al. Cancer Immunol Immunother. 2013 Feb;62(2):257-71. doi: 10.1007/s00262-012-1329-y. Epub 2012 Aug 14. Cancer Immunol Immunother. 2013. PMID: 22890822 Free PMC article.
Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts.
Quezada SA, Simpson TR, Peggs KS, Merghoub T, Vider J, Fan X, Blasberg R, Yagita H, Muranski P, Antony PA, Restifo NP, Allison JP. Quezada SA, et al. J Exp Med. 2010 Mar 15;207(3):637-50. doi: 10.1084/jem.20091918. Epub 2010 Feb 15. J Exp Med. 2010. PMID: 20156971 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer
Other Literature Sources
- The Lens - Patent Citations Database
Research Materials
- NCI CPTC Antibody Characterization Program